482R-1

p63 (EP174) Rabbit Monoclonal Primary Antibody

• UNSPSC-Code: 12352203

Eigenschaften

• Biologische Quelle: rabbit
• Qualitätsniveau: 100; 500
• Konjugat: unconjugated
• Antikörperform: culture supernatant
• Antikörper-Produkttyp: primary antibodies
• Klon: EP174
• Beschreibung: For In Vitro Diagnostic Use in Select Regions
• Form: buffered aqueous solution
• Speziesreaktivität: human
• Verpackung: vial of 0.1 mL concentrate (482R-14); vial of 0.1 mL concentrate, Research Use Only (482R-14-RUO); vial of 0.5 mL concentrate (482R-15); vial of 1.0 mL concentrate (482R-16); vial of 1.0 mL concentrate, Research Use Only (482R-16-RUO); vial of 1.0 mL pre-dilute ready-to-use, Research Use Only (482R-17-RUO); vial of 1.0 mL pre-dilute, ready to use (482R-17); vial of 25.0 mL pre-dilute ready-to-use (482R-10); vial of 25.0 mL pre-dilute ready-to-use, Research Use Only (482R-10-RUO); vial of 7.0 mL pre-dilute, ready to use (482R-18); vial of 7.0 mL pre-dilute, ready to use, Research Use Only (482R-18-RUO)
• Hersteller/Markenname: Cell Marque
• Methode(n): immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable (1:100-1:200 (concentrated))
• Isotyp: IgG
• Kontrolle: lung (squamous cell carcinoma), prostate
• Versandbedingung: wet ice
• Lagertemp.: 2-8°C
• Visualisierung: nuclear

Beschreibung

Allgemeine Beschreibung

p63 is a transcription factor that regulates many cell activities, including cell proliferation, maintenance, differentiation, adhesion, and apoptosis.¹ It has been found to be a sensitive and specific marker of myoepithelial and basal cell populations in prostate, breast, skin, and salivary gland. Additionally, p63 has also demonstrated immunohistochemical utility in identifying benign and malignant breast lesions.² In prostatic carcinomas, it can also be used to recognize benign glands adjacent to malignant glands.³ p63 can also be used to differentiate adenocarcinoma of the lungs, where it is usually negative, from squamous cell carcinoma, which can be useful for advanced stages of the carcinoma where surgery is no longer an option.⁴

Qualität

United States - IVD
Canada - RUO
European Union - IVD
Japan - RUO

Physikalische Form

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide.

Angaben zur Herstellung

Download the IFU specific to your product lot and format
Note: This requires a keycode which can be found on your packaging or product label.

Sonstige Hinweise

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

Sicherheitshinweise

• Lagerklassenschlüssel: 12 - Non Combustible Liquids
• WGK: WGK 2